A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5377 (2006.01) A61P 25/08 (2006.01) A61P 25/22 (2006.01)
Patent
CA 2501772
The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4(4-morpholinyl)-2,5-dihydro-1H-imidazol-2- one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
L'invention concerne l'utilisation de dihydroimidazolones substitués, en particulier de [1-(4-Chlorophényl)-4(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) ou d'un sel physiologiquement acceptable de ceux-ci, pour le traitement de l'épilepsie chez le chien.
Dost Rita
Lankau Hans-Joachim
Loscher Wolfgang
Rundfeldt Chris
Tipold Andrea
Boehringer Ingelheim Vetmedica Gmbh
Fetherstonhaugh & Co.
LandOfFree
Use of dihydroimidazolones for the treatment of epilepsy in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of dihydroimidazolones for the treatment of epilepsy in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dihydroimidazolones for the treatment of epilepsy in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1481824